|
|
The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.
Women are 50% to 75% more likely than men to experience an adverse drug reaction.
According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.
During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.
More than 4.4billion prescriptions were dispensed within the United States in 2016.